PAA
Peregrine Asset Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,326
| Closed | -$5.04M | – | 168 |
|
|
2023
Q2 | $5.04M | Buy |
+14,326
| New | +$5.04M | 3.87% | 7 |
|
|
2022
Q3 | – | Sell |
-14,916
| Closed | -$4.2M | – | 87 |
|
|
2022
Q2 | $4.2M | Buy |
+14,916
| New | +$4.2M | 3.06% | 11 |
|
|
2020
Q1 | – | Sell |
-2,000
| Closed | -$438 | – | 156 |
|
|
2019
Q4 | $438 | Buy |
+2,000
| New | +$438 | 0.1% | 71 |
|
|
2018
Q4 | – | Sell |
-13,562
| Closed | -$2.61M | – | 126 |
|
|
2018
Q3 | $2.61M | Buy |
+13,562
| New | +$2.61M | 1.18% | 28 |
|
|
2017
Q4 | – | Sell |
-28,349
| Closed | -$4.31M | – | 121 |
|
|
2017
Q3 | $4.31M | Buy |
+28,349
| New | +$4.31M | 2.27% | 16 |
|